Gun Almqvist

1.7k total citations · 2 hit papers
23 papers, 972 citations indexed

About

Gun Almqvist is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Gun Almqvist has authored 23 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology and Allergy. Recurrent topics in Gun Almqvist's work include Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (8 papers) and Respiratory and Cough-Related Research (7 papers). Gun Almqvist is often cited by papers focused on Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (8 papers) and Respiratory and Cough-Related Research (7 papers). Gun Almqvist collaborates with scholars based in Sweden, United Kingdom and United States. Gun Almqvist's co-authors include Gene Colice, Åsa Hellqvist, Janet M. Griffiths, Primal Kaur, Karin Bowen, Andrew Menzies‐Gow, Sandhia Ponnarambil, Michael E. Wechsler, Christopher E. Brightling and Elliot Israel and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Gun Almqvist

21 papers receiving 958 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

2021 606 citations Andrew Menzies‐Gow, Michael E. Wechsler et al. New England Journal of Medicine profile →
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

2025 35 citations Joseph K. Han, Martin Desrosiers et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Gun Almqvist

Since Specialization

Citations

This map shows the geographic impact of Gun Almqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gun Almqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gun Almqvist more than expected).

Fields of papers citing papers by Gun Almqvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gun Almqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gun Almqvist. The network helps show where Gun Almqvist may publish in the future.

Co-authorship network of co-authors of Gun Almqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Gun Almqvist. A scholar is included among the top collaborators of Gun Almqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gun Almqvist. Gun Almqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps breakdown → 2025 ·New England Journal of Medicine ·(unknown), Joseph K. Han, Martin Desrosiers, Claire Hopkins, Stella E. Lee, Joaquim Mullol, Oliver Pfaar, Ting Li, (unknown), Gun Almqvist, Mary Kay Margolis, Julie McLaren, Shankar Jagadeesh, J. Mackay, Ayman Megally, Åsa Hellqvist, Vaishali S. Mankad, (unknown), (unknown)	35
2	Efficacy And Safety Of Tezepelumab In Adults With Severe Chronic Rhinosinusitis With Nasal Polyps: Results From The Phase 3 WAYPOINT Study 2025 ·Journal of Allergy and Clinical Immunology ·Joseph K. Han, Brian J. Lipworth, Martin Desrosiers, Claire Hopkins, Stella Lee, Joaquim Mullol, Oliver Pfaar, Ting Li, (unknown), Gun Almqvist, Mary Kay Margolis, Julie McLaren, Shankar Jagadeesh, J. Mackay, Vaishali S. Mankad, (unknown), Sandhia Ponnarambil	0
3	Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Michael E. Wechsler, Daiana Stolz, Njira Lugogo, (unknown), Gun Almqvist, (unknown), (unknown), (unknown), Christopher S. Ambrose	3
4	Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study 2024 ·(unknown), Mona Bafadhel, Christopher E. Brightling, Klaus F. Rabe, MeiLan K. Han, Mohit Bhutani, Jean Bourbeau, S. Christenson, Mark T. Dransfield, Parameswaran Nair, (unknown), (unknown), Gun Almqvist, (unknown), (unknown), Néstor A. Molfino, Sandhia Ponnarambil	0
5	Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study 2024 ·Dave Singh, Mona Bafadhel, Christopher E. Brightling, Klaus F. Rabe, MeiLan K. Han, Mohit Bhutani, Jean Bourbeau, S. Christenson, Mark T. Dransfield, Parameswaran Nair, (unknown), (unknown), Gun Almqvist, (unknown), (unknown), Néstor A. Molfino, Sandhia Ponnarambil, (unknown)	4
6	Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults With Severe Asthma: Results From the DESTINATION Study 2023 ·Andrew Menzies‐Gow, (unknown), Christopher E. Brightling, (unknown), E. Israel, (unknown), Sandhia Ponnarambil, (unknown), Gun Almqvist, (unknown), Nathalie Martin, (unknown), Gene Colice	3
7	One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study 2022 ·Journal of Asthma ·Masaharu Shinkai, Motohiro Ebisawa, (unknown), Satomi Takeuchi, Hiroshi Okada, (unknown), Nobuya Hayashi, (unknown), Gene Colice, Gun Almqvist	11
8	Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults with Severe Asthma 2021 ·(unknown), (unknown), Christopher E. Brightling, (unknown), (unknown), Tobias Welte, Janet M. Griffiths, (unknown), (unknown), Gun Almqvist, Primal Kaur, Tor Skärby, Gene Colice	13
9	Reductions in Inflammatory Biomarkers in Patients with Oral Corticosteroid-Dependent Asthma Treated with Tezepelumab 2021 ·Michael E. Wechsler, (unknown), Christopher E. Brightling, Piotr Kuna, S Korn, Tobias Welte, Janet M. Griffiths, Kinga Sałapa, Åsa Hellqvist, Gun Almqvist, Primal Kaur, Tor Skärby, Gene Colice	1
10	SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma 2020 ·Respiratory Research ·Michael E. Wechsler, Gene Colice, Janet M. Griffiths, Gun Almqvist, Tor Skärby, (unknown), Primal Kaur, Karin Bowen, Åsa Hellqvist, May Mo, Esther García Gil	60
11	NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma 2020 ·Respiratory Research ·Andrew Menzies‐Gow, Gene Colice, Janet M. Griffiths, Gun Almqvist, Sandhia Ponnarambil, Primal Kaur, (unknown), Karin Bowen, Åsa Hellqvist, May Mo, Esther García Gil	70
12	Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study 2019 ·Respiratory Research ·Brian Leaker, Dave Singh, S. Lindgren, Gun Almqvist, Leif Eriksson, (unknown), Brian O’Connor	20
13	The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials 2017 ·Trials ·Paul M. O’Byrne, J. Mark FitzGerald, Nanshan Zhong, Eric D. Bateman, Peter J. Barnes, Christina Keen, Gun Almqvist, Kristine Pemberton, Carin Jorup, Stefan Ivanov, Helen K. Reddel	31
14	Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study 2015 ·Inflammation Research ·Lennart Greiff, Cecilia Ahlström‐Emanuelsson, (unknown), Gun Almqvist, Morgan Andersson, Anders Cervin, (unknown), S. Lindgren, Anders Mårtensson, (unknown), (unknown)	21
15	Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis 2012 ·Respiratory Research ·Lennart Greiff, Anders Cervin, Cecilia Ahlström‐Emanuelsson, Gun Almqvist, Morgan Andersson, (unknown), Leif Eriksson, Edward D. Högestätt, Anders Källén, Per Norlén, (unknown), (unknown)	44
16	The Effects Of The Novel Toll-Like Receptor 7 (TLR7) Agonist AZD8848 On Allergen-Induced Responses In Patients With Mild Asthma 2012 ·Brian Leaker, (unknown), S. Lindgren, Anders Källén, Gun Almqvist, (unknown), Brian O’Connor	4
17	Efficacy And Tolerability Of The Toll-Like Receptor 7 Agonist AZD8848 In Patients With Seasonal Allergic Rhinitis 2012 ·Lennart Greiff, Anders Cervin, S. Lindgren, (unknown), Gun Almqvist, (unknown)	1
18	Cutaneous delayed-type hypersensitivity reactions in smokers with chronic bronchitis and recurrent exacerbations: comparison with asymptomatic smokers and never-smokers 1999 ·Respiratory Medicine ·Ingemar Qvarfordt, (unknown), S Larsson, Gun Almqvist, J. Rollof	4
19	Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations 1998 ·European Respiratory Journal ·Ingemar Qvarfordt, (unknown), S Larsson, Gun Almqvist, J. Rollof, Thomas Bengtsson, (unknown)	17
20	Discrimination between rival dosing histories. 1997 ·Pharmaceutical Research ·E. Niclas Jonsson, Janet R. Wade, Gun Almqvist, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact